HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Otto C Boerman Selected Research

Escherichia coli Infections

11/2007Preclinical evaluation of technetium 99m-labeled P1827DS for infection imaging and comparison with technetium 99m IL-8.
7/2004Relationship between neutrophil-binding affinity and suitability for infection imaging: comparison of (99m)Tc-labeled NAP-2 (CXCL-7) and 3 C-terminally truncated isoforms.
7/2003A bivalent leukotriene B(4) antagonist for scintigraphic imaging of infectious foci.
7/200299mTc-HMPAO-labeled autologous versus heterologous leukocytes for imaging infection.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Otto C Boerman Research Topics

Disease

150Neoplasms (Cancer)
12/2022 - 02/2002
31Renal Cell Carcinoma (Grawitz Tumor)
01/2020 - 08/2003
16Neoplasm Metastasis (Metastasis)
12/2022 - 10/2003
16Prostatic Neoplasms (Prostate Cancer)
10/2020 - 10/2011
16Infections
01/2010 - 03/2002
15Squamous Cell Carcinoma of Head and Neck
07/2021 - 08/2003
13Colorectal Neoplasms (Colorectal Cancer)
12/2019 - 02/2006
13Inflammation (Inflammations)
01/2017 - 07/2003
11Hypoxia (Hypoxemia)
10/2022 - 08/2005
10Melanoma (Melanoma, Malignant)
03/2016 - 01/2003
9Head and Neck Neoplasms (Head and Neck Cancer)
10/2022 - 10/2003
8Reperfusion Injury
01/2012 - 01/2005
7Arthritis (Polyarthritis)
01/2018 - 01/2002
7Abscess
11/2007 - 03/2002
6Residual Neoplasm
12/2019 - 10/2003
6Carcinoma (Carcinomatosis)
01/2017 - 02/2007
6Peritoneal Neoplasms
02/2009 - 01/2006
5Experimental Arthritis
01/2018 - 07/2003
5Neuroendocrine Tumors (Neuroendocrine Tumor)
01/2018 - 09/2007
5Ovarian Neoplasms (Ovarian Cancer)
10/2017 - 02/2008
5Thyroid Neoplasms (Thyroid Cancer)
01/2017 - 08/2011
5Non-Hodgkin Lymphoma (Lymphosarcoma)
05/2007 - 05/2003
4Type 1 Diabetes Mellitus (Autoimmune Diabetes)
01/2017 - 05/2014
4Colonic Neoplasms (Colon Cancer)
01/2017 - 11/2010
4Rheumatoid Arthritis
07/2015 - 12/2010
4Breast Neoplasms (Breast Cancer)
01/2015 - 10/2010
4Ischemia
01/2012 - 01/2005
4Escherichia coli Infections
11/2007 - 07/2002
3Insulinoma
11/2017 - 07/2010
3Kidney Neoplasms (Kidney Cancer)
01/2016 - 01/2003

Drug/Important Bio-Agent (IBA)

42Peptides (Polypeptides)IBA
09/2019 - 11/2002
41Monoclonal AntibodiesIBA
01/2018 - 01/2003
36AntigensIBA
01/2019 - 01/2003
33Radioisotopes (Radionuclides)IBA
01/2019 - 08/2003
28AntibodiesIBA
01/2019 - 03/2003
22Carbonic Anhydrase IXIBA
10/2022 - 08/2005
21Proteins (Proteins, Gene)FDA Link
10/2022 - 10/2003
18G250 monoclonal antibodyIBA
07/2021 - 09/2003
17Pentetic Acid (DTPA)FDA LinkGeneric
10/2022 - 09/2003
171,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA
12/2019 - 11/2002
11AcidsIBA
01/2017 - 09/2003
11Cetuximab (Erbitux)FDA Link
01/2016 - 08/2011
9Carcinoembryonic AntigenIBA
04/2020 - 07/2004
8ErbB Receptors (EGF Receptor)IBA
01/2016 - 08/2011
8Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
11/2014 - 05/2008
7Immunoglobulin G (IgG)IBA
09/2019 - 08/2012
7Somatostatin Receptors (Somatostatin Receptor)IBA
01/2018 - 03/2006
7Bevacizumab (Avastin)FDA Link
12/2014 - 06/2008
7Integrin beta3 (GPIIIa)IBA
12/2009 - 11/2002
6IntegrinsIBA
01/2018 - 11/2007
6Biological ProductsIBA
01/2018 - 01/2007
6Therapeutic UsesIBA
01/2018 - 09/2003
6Liposomes (Liposome)IBA
01/2017 - 01/2002
6Neoplasm Antigens (Tumor Antigens)IBA
03/2016 - 09/2002
6HaptensIBA
02/2015 - 03/2003
6Interleukin-8 (Interleukin 8)IBA
11/2007 - 03/2002
5Pharmaceutical PreparationsIBA
01/2020 - 05/2014
5pimonidazoleIBA
12/2019 - 08/2005
5Glycine (Aminoacetic Acid)FDA LinkGeneric
09/2019 - 11/2007
5DOTA- tyrosyl- lysyl(histaminyl- succinyl- glycyl)- glutamyl- lysyl(histaminyl- succinyl- glycyl)amideIBA
01/2017 - 04/2010
5VaccinesIBA
03/2016 - 09/2002
5Insulin-Like PeptidesIBA
01/2015 - 12/2011
5teprotumumabIBA
09/2013 - 10/2010
5Peptide Receptors (Peptide Receptor)IBA
12/2010 - 03/2006
5cyclic arginine-glycine-aspartic acid peptideIBA
12/2009 - 11/2006
5Leukotriene B4IBA
08/2007 - 01/2004
4Immunoconjugates (Immunoconjugate)IBA
01/2018 - 08/2003
4Biomarkers (Surrogate Marker)IBA
01/2017 - 11/2011
4Indium-111IBA
01/2016 - 04/2009
4Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
02/2015 - 06/2008
4LigandsIBA
01/2015 - 07/2003
4arginyl-glycyl-aspartic acidIBA
05/2013 - 11/2002
4Cholecystokinin (Pancreozymin)IBA
09/2012 - 04/2011
4Cholecystokinin B ReceptorIBA
09/2012 - 04/2010
4PhosphatidylserinesIBA
06/2011 - 05/2007
4Somatostatin (Somatotropin Release-Inhibiting Factor)IBA
12/2010 - 03/2006
4Adenosine (Adenocard)FDA LinkGeneric
06/2009 - 01/2005
4DPC11870-11IBA
05/2005 - 07/2003
3Histamine (Histamine Dihydrochloride)FDA Link
09/2019 - 06/2009
3IndiumIBA
01/2019 - 10/2005
3Coloring Agents (Dyes)IBA
01/2018 - 06/2014
3Arginine (L-Arginine)FDA Link
01/2018 - 11/2007
3Phosphates (Orthophosphate)IBA
01/2018 - 05/2007
3procaine isothiocyanate (PRIT)IBA
01/2017 - 11/2010
3Monophenol Monooxygenase (Tyrosinase)IBA
03/2016 - 04/2009
3LutetiumIBA
01/2016 - 09/2013
3GlucocorticoidsIBA
07/2015 - 01/2002

Therapy/Procedure

57Therapeutics
10/2022 - 01/2003
37Radioimmunotherapy
01/2017 - 03/2003
14Radiotherapy
01/2019 - 12/2005
9Immunotherapy
01/2021 - 08/2003
9Drug Therapy (Chemotherapy)
01/2019 - 02/2006
9Aftercare (After-Treatment)
01/2018 - 07/2003
6Cytoreduction Surgical Procedures
12/2022 - 02/2006
6Computer-Assisted Surgery (Image Guided Surgery)
04/2020 - 06/2014
5Intravenous Administration
02/2011 - 07/2003
5Gamma Cameras (Gamma Camera)
04/2009 - 03/2002
4Laparotomy
04/2012 - 11/2006
3Photochemotherapy (Photodynamic Therapy)
12/2019 - 01/2019
3Precision Medicine
01/2019 - 01/2015